|
STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape. |
| |
|
Employment - NeoGenomics Laboratories |
Consulting or Advisory Role - Wendell O Scott, MD Consulting |
| |
|
Employment - NeoGenomics Laboratories |
Stock and Other Ownership Interests - Allergan; NeoGenomics Laboratories |
| |
|
Employment - Neogenomics Laboratories |
Consulting or Advisory Role - Cynvenio Biosystems |
| |
|
No Relationships to Disclose |
| |
|
Employment - Neogenomics Laboratories |
Leadership - NeoGenomics Laboratories |
Stock and Other Ownership Interests - NeoGenomics Laboratories |
| |
|
Employment - NeoGenomics Laboratories |